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ABSTRACT 
Background: Advance care planning (ACP), a process of discussion and review con-
cerning future care in the event of losing capacity. Aimed at improving the appropri-
ateness and quality of care, it is also often considered a means of controlling health 
spending at the end of life.  
Aim: To review and summarise economic evidence on advance care planning.  
Design: A systematic review of academic literature.  
Data sources: We searched for English language peer-reviewed journal articles, 1990 
to 2014, using relevant research databases; PubMed; ProQuest; CINAHL Plus with 
Full Text; EconLit; PsycINFO; SocINDEX with Full Text and International Bibliog-
raphy of the Social Sciences. Empirical studies using statistical methods in which 
ACP and costs are analytic variables were included.  
Results: There are no published cost-effectiveness studies. Included studies focus on 
health care savings, usually associated with reduced hospital care. ACP may be asso-
ciated with healthcare savings for some people, in some circumstances, such as peo-
ple living with dementia in the community, in nursing homes or in areas with high 
end of life care spending.  
Conclusions: There is need for clearer articulation of the likely mechanisms by which 
ACP can lead to reduced care costs or improved cost-effectiveness, particularly for 
people who retain capacity. There is a need to consider wider costs, including inter-
vention costs and the costs of substitute health, social and informal care. There is no 
evidence that ACP is more expensive. Economic outcomes should be considered in 
the context of quality benefits.  
 
 
What is already known about the topic? 
• In the US there is legislation to promote advance care planning, while advance 
care planning is a key feature of UK policy on end of life care  
• Aimed at improving the appropriateness and quality of care, advance care plan-
ning is also often considered to be a means of making better use of healthcare re-
sources at the end of life  
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• Whether advance care planning can lead to cost savings or cost-effectiveness 
gains is the subject of ongoing debate  
   
What this paper adds? 
• This paper provides an overview of empirical studies, published since 1990, re-
porting on economic outcomes associated with advance care planning 
• Research evidence is limited and heterogeneous but suggests that advance care 
planning may lead to health care savings for some people in some circumstances 
• Cost measures are varied, with no studies taking a societal perspective and many 
relevant costs omitted  
 
Implications for practice: theory or policy? 
• Advance care planning may lead to cost savings in some circumstances and is un-
likely to be more expensive 
• There is a need for clearer articulation of the likely mechanisms by which advance 
care plans can lead to reduced care costs or cost-effectiveness gains  
• Economic outcomes should be considered in the wider context of quality benefits 
 
 
1. Background  
 
Advance care planning (ACP) is a voluntary process of discussion and review con-
cerning future care and treatment in the event of losing capacity. ACP conversations 
need not be documented although usually they are. The legal and policy framework 
for advance care planning varies across countries. In the UK, advance statements set 
out general preferences to inform best-interest decisions, while advance decisions to 
refuse treatment are legally binding and regulated by the Mental Capacity Act (2005) 
in England and Wales and, with similar provision, by common law in Scotland and 
Northern Ireland. Advance decisions may also include assigning proxy decision-
making powers through power of attorney, Lasting Power of Attorney (LPA) in Eng-
land and Wales and Power of Attorney (PoA) in Scotland. In Northern Ireland is there 
is no legal provision for health and welfare proxy decision-making. ACP is an im-
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portant element in UK policy on end of life care, featuring in national end of life 
strategies for England and Wales (Department of Health, 2008), Scotland (Scottish 
Government, 2008) and Northern Ireland (Department of Health, Social Services and 
Public Health, 2010). In the US, advance decisions are known as advance directives 
(ADs) and the Patient Self-Determination Act (PSDA, 1990) places an obligation on 
healthcare facilities to inform patients about their rights to make an advance 
healthcare directive. Advance directives may also include assigning Durable Power of 
Attorney (DPoA).  
 
Potential benefits of ACP include care aligned with preferences, reduced misunder-
standings and conflict between medical staff and families, fewer interventions of lim-
ited clinical value, earlier access to palliative care, reduced emergency hospital ad-
missions, fewer hospital deaths and reduced anxiety and depression experienced by 
bereaved carers (Brinkman-Stoppelenburg et al., 2014; GMC, 2010). Although pri-
marily concerned with improving the appropriateness and quality of care, ACP is also 
often considered a means of controlling health spending and making better use of re-
sources at the end of life (Marckmann and In Der Schmitten, 2013). Whether ACP 
can lead to cost savings or cost-effectiveness gains in practice has been an ongoing 
source of debate. 
 
2. Aims 
 
Our aim was to systematically review the academic literature for empirical studies 
that report on economic outcomes potentially associated with ACP, published be-
tween 1990 and 2014. We included studies in which ACP forms an important and 
substantial element of a wider palliative care or support programme. In this paper, we 
present and critically discuss the evidence, and make proposals for future research in 
this area.  
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3. Methods 
 
A systematic search of academic literature was conducted with support from a re-
search librarian, following national guidance on the conduct of systematic reviews in 
healthcare (Centre for Review and Dissemination, 2008). We searched for English 
language peer-reviewed journal articles, 1990 to 2014, using relevant research data-
bases (PubMed; ProQuest; CINAHL Plus with Full text; EconLit; PsycINFO; So-
cINDEX with Full Text and International Bibliography of the Social Sciences), using 
relevant search terms (Box 1).  
 
 
Box 1: Search terms 
“advance care plan” or “advanced care plan” or “advance care plans” or “advanced 
care plans” or “advance care planning” or “advanced care planning” or “advance 
statement” or “advanced statement” or “advance statements” or “advanced state-
ments” or “advance directive” or “advanced directive” or “advance directives” or 
“advanced directives” or “advance decision” or “advanced decision” or “advance de-
cisions” or “advanced decisions” or “living will” or "end of life planning" or "end-of-
life planning" or "EOL planning" or "end of life conversation" or "end-of-life conver-
sation" or "EOL conversation" or "end of life discussion" or "end-of-life discussion" 
or "EOL discussion" or "end of life care planning" or "end-of-life care planning" or 
"EOL care planning" pr "end of life counselling" or "end-of-life counselling" or "EOL 
counselling" or "end of life counseling" or "end-of-life counseling" or "EOL counsel-
ing" 
 
AND 
 
“cost” or “costs” or “spend” or “spending” or “expenditure” or “savings” 
 
For each of the selected databases, we searched for ACP terms in the title, abstract 
and keywords. We considered that if one of the selected terms for ACP did not occur 
in the abstract, title or keywords, then the study was unlikely to include ACP as a key 
variable in empirical research. Conservatively, however, we allowed for the cost-
related terms to appear anywhere, including in the full text (with the exception of 
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PubMed, where the search facility allowed only titles and abstracts to be searched). 
The initial search generated a total of 474 journal articles (following removal of 89 
duplicates). In addition, we separately searched, using the cost-related terms, all 
PubMed articles categorised using the Mesh term, ‘Advance Care Planning’. This 
MESH term was introduced in 2003. It draws together published articles on ACP and 
is defined as ‘discussions with patients and/or their representatives about the goals 
and desired direction of the patient's care, particularly end of life care, in the event 
that the patient is or becomes incompetent to make decisions’. This produced 108 ad-
ditional articles (after removing 131 duplicates with the original list). In total, across 
all searches, we identified 582 unique articles. The lead author, assisted by another 
researcher, reviewed titles and abstracts and articles that turned out to be unrelated to 
ACP for end of life (n=102) were removed, leaving 480 articles in total.  
 
Abstracts and, where necessary, full papers for the 480 articles were reviewed against 
inclusion and exclusion criteria. Inclusion criteria were: 
 
• an empirical study using statistical methods  
• ACP included as an analytical variable, defined as including ADs or advance de-
cisions; advance care statements or written plans; and/or ACP discussions  
• a comparison between people engaging and not engaging in ACP  
• costs, expenditure or savings included as an analytical variable. 
 
Articles were excluded which did not meet the above criteria. Other exclusion criteria 
were:  
 
• studies of psychiatric patients  
• studies of children (aged under 18) 
• studies solely about medical orders (e.g. do-not-hospitalise; do-not-resuscitate) 
• studies solely about LPA or DPOA 
 
We included studies that considered ACP as part of a wider palliative care or end of 
life intervention as long as ACP formed an important and substantial element. Alt-
hough we were aware that this meant that the impact of ACP could not be isolated 
from the rest of the intervention, we included such studies to provide a comprehensive 
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overview of ACP-related studies reporting economic outcomes. DPOA and specific 
medical orders (e.g. do-not-resuscitate or do-not-hospitalize orders) were not searched 
for separately, as we were interested in these only where they were part of a broader 
written advance care plan or ACP process. ,The reasons for this were that DPOA does 
not always involve discussion or documentation of a patient’s  wishes, while medical 
orders are often applied late, often just days before death, and not always with full 
discussion with either the patient or their carers or family members (Brinkman-
Stoppelenburg et al., 2014). Two articles that were found solely to cover DPOA or 
specific medical orders were excluded (Maksoud et al., 1993; Fonk et al., 2012). In 
one case a study that otherwise met the criteria for inclusion was removed since, alt-
hough ACP formed an important part of the intervention (in three UK nursing 
homes), in practice, only 40 out of the total of 165 patients received any ACP facilita-
tion and support (although other aspects of the programme were implemented fully) 
(Lisk et al., 2012).  
 
Where systematic and narrative reviews were identified in the search, they were re-
viewed with the aim of identifying further empirical studies not identified in the orig-
inal search. Reference lists in included articles were also hand-searched for additional 
studies of relevance. One study was identified by these means (Gade et al., 2008). A 
further study, from the UK, independently known to the authors, was also included 
(Baker et al. 2012). This appeared in the British Journal of General Practice, which 
was not included in the selected databases. In total 24 full papers were reviewed. The 
final number of included studies was 18.  
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Figure 1: Flowchart showing selection process 
 
 
Following selection, descriptive data about the 18 included studies was extracted, 
covering year of publication, country, type of ACP activity or intervention, target 
population and setting, sample and sample size, study design, economic outcome 
measures used and results. The level of evidence was graded according to the schema 
used by Brinkman-Stoppelenburg et al. (2014) in their systematic review of (non-
economic) outcomes associated with ACP, which were adapted from criteria original-
ly proposed by Higginson et al. (2002) (Box 2). The results from this data extraction 
are presented in Table 1.  
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BOX 2: Definitions used for the grades of evidence (Reproduced from Brinkman-Stoppelenburg, 
2014, based on criteria originally identified by Higginson et al., 2002)  
 
Grade I: Randomised controlled trial (RCT) or RCT review 
IA Calculation of sample size* and accurate, standard definition of outcome variables 
IB Accurate and standard definition of outcome variables. 
IC Neither of the above 
Grade II: Prospective study with a comparison group (non-randomised controlled trial, good observa-
tional study) or retrospective study which controls effectively for confounding variables 
IIA Calculation of sample size* and accurate, standard definition of outcome variables and adjust-
ments for the effects of important confounding variables 
IIB One or more of the above 
IIC Neither of the above 
Grade III: Retrospective or observational or cross-sectional studies 
IIIA Comparison group, calculation of sample size* and accurate, standard definition of outcome 
variables 
IIIB One or more of the above 
IIIC Neither of the above 
 
* If the number of respondents was 1000 or more, we considered the criterion of ‘calculation of sample 
size’ to be met. 
 
 
 
Further data, focusing on key features of definition and design, were extracted to in-
form our discussion. Throughout we use US terminology (e.g. AD), reflecting the 
predominance of US-based research literature in this area, but when not used in refer-
ence to a specific study or otherwise stated, we intend this to include the parallel 
terms. When discussing US studies, the term hospice refers to palliative care provided 
in any setting where life expectancy is less than 6 months. When discussing UK stud-
ies, hospice refers to a UK hospice organisation, providing palliative care to people 
with a terminal diagnosis.  
4. Results 
 
Table 1 summarizes the results from the review.  
 
[insert table 1 here] 
 
 
Country 
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Research in this area predominantly comes from the US, following the Patient Self-
Determination Act (1990). All but four of the 18 included studies are from the US, 
with two from the UK (Abel et al., 2013; Baker et al., 2012), one from Canada 
(Molloy et al., 2000) and one from Singapore (Teo et al., 2014).  
 
Study design 
 
Five of the studies use randomised designs; four randomised controlled trials (RCTs) 
(Hamlet et al., 2010; Engelhardt et al., 2006; Teno et al., 1997; Gade et al., 2008) and 
one cluster-randomised controlled trial (Molloy et al., 2000). These evaluate different 
types of ACP intervention in a variety of settings, including nursing homes (Molloy et 
al., 2000), hospitals (Gade et al., 2008; Teno et al., 1997), a home-based telephone 
counselling intervention (Hamlet et al., 2010) and a complex care and coordination 
programme delivered through Veteran Affairs medical centers (Engelhardt et al., 
2006). The remaining studies are observational; three non-randomised controlled de-
signs (Teo et al., 2014; Baker et al., 2012 and Yoo et al., 2012) and ten natural exper-
iments.  
 
Study samples 
 
The studies are based on a wide variety of samples. Three studies use data from the 
US Health and Retirement Study, with its nationally representative sample of older 
people (Nicholas et al., 2014; Nicholas et al., 2011; Kelley et al, 2011), while Kessler 
and McClellan (2004) use a large random sample of Medicare beneficiaries. The re-
maining studies use selective samples, defined either by patient characteristics, for 
example, high-cost and low-income Medicare beneficiaries (Hamlet et al., 2010), or 
by care setting, with seven of the studies based on hospital samples (Yoo et al., 2012; 
Tan and Jatoi, 2011; Zhang et al., 2008; Gade et al., 2008; Teno et al., 1997; Weeks et 
al., 1994; Chambers et al., 1994). Some studies use samples defined by both patient 
characteristics and care setting, for example, patients admitted to an inpatient oncolo-
gy unit in a US hospital (Tan and Jatoi, 2011). While selective samples are appropri-
ate for evaluating interventions specific to these populations and settings, care needs 
to be taken in generalising findings to individuals beyond these groups. Hospital sam-
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ples, for example, are likely to over-represent those who are least able to die at home 
(Wholihan, 2012). Sample sizes range from under 50 (Baker et al., 2012) to around 
3000 or more (Nicholas et al., 2014; Nicholas et al., 2011; Kelley et al., 2011; Hamlet 
et al., 2010; Teno. et al., 1997), with one study, looking at the economic impact of 
state level laws incentivising compliance with the Patient Self Determination Act 
(1990), with a sample of over 75,000.  
 
Definition of ACP  
 
Of the 18 included studies, eight are non-intervention studies, exploring the impact of 
ACP in general. These cover different types of ACP activity, operationalised for re-
search in a range of ways (Table 2).  
 
Table 2: Operational definition of ACP in general (non-intervention) studies 
 
Nicholas et al., 2014 
A proxy report of a decedent having a treatment-limiting, written AD; US 
Health and Retirement Study 
Nicholas et al., 2011 
A proxy report of a decedent having a treatment-limiting, written AD; US 
Health and Retirement Study 
Kelley et al., 2011 
A proxy report of a decedent having a written AD or having engaged in an 
end of life discussion; US Health and Retirement Study 
Tan and Jatoi, 2011 
Record of an AD completed prior to hospital admission in retrospectively 
reviewed medical records 
Zhang et al., 2008 
Self-report during baseline interview of having had a prior discussion with 
their doctor about end of life preferences. 
Kessler and McClellan, 
2004 
State with laws enhancing incentives for compliance with Patient Self-
Determination Act (PSDA,1990) 
Weeks et al., 1994 
Record of an AD completed prior to a terminal hospital admission in retro-
spectively reviewed medical records 
Chambers et al., 1994 
Record of an AD entered into patient notes within 48 hours of terminal hospi-
tal admission in retrospectively reviewed medical records 
 
12 
These general ACP studies, except for Zhang et al. (2009), rely entirely on secondary 
data sources and provide limited information about the process of ACP, such as when 
and how ACP was first initiated, whether ACP was facilitated by a trained profes-
sional or the frequency of review, factors known to influence the quality and effec-
tiveness of ACP (Brinkman-Stoppelenburg et al., 2014; Detering et al., 2010; Lorenz 
and Lynn, 2004; Ng and Chong, 2013). The quality of ADs cannot be presumed to be 
always high, with Tan and Jatoi (2011) noting that around a third of the 46 ADs held 
by patients in their study were insufficiently specific. Several studies attempt to dis-
tinguish ACP from the documenting of medical decision-making in the last weeks and 
days of life, with two studies specifying that ADs should have been initiated prior to 
the index hospital admission (Weeks et al., 1994; Tan and Jatoi, 2011). Weeks et al. 
(1994) also gather data about when these ADs were first established, finding it to be a 
median of eight months prior to hospital admission. Zhang et al. (2009) similarly re-
quire that end of life discussions with a physician should have occurred prior to study 
enrolment, with participants enrolled onto the study an average of 6 months prior to 
death.  
 
The remaining ten studies focus on specific interventions designed to promote ACP, 
(Table 3). These are varied, but are most commonly counselling and support services, 
generally led by nurses and social workers, with the aims, variously, of promoting and 
supporting ACP, assisting in end of life decision-making and optimizing patient-
physician communication. When delivered as part of a wider intervention, these in-
volve additional measures to identify and address unmet support needs. They may in-
volve specialist palliative care physicians and nurses, and commonly allow for refer-
ral to other specialist services.   
 
Table 3: Description of ACP interventions for included intervention studies 
 
Teo et al., 2014 
Project CARE, a nursing home-based ACP and palliative care intervention in 
Singapore. Residents at risk of dying within 6-12 months are approached to 
complete an ACP, nursing home staff receive training and hospital-based phy-
sicians and nurses make regular visits. 
Abel et al., 2013 
A hospice in the South West of England, where preferred place of death is rou-
tinely discussed and recorded in an electronic patient record 
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Lukas et al., 2013 
Optimising Advanced Complex Illness Support (OACIS), a home-based, non-
hospice palliative programme in the US. Nurse practitioners, supported by 
physicians, undertake an initial 1-2 hour consultation, complete a ‘goals of 
care’ transcript, assist the patient to complete an AD where appropriate, and 
undertake follow-up visits. Nurse practitioners actively liaise with primary care 
physicians and managing specialists and make referrals to other services. 
Baker et al., 2012 
Intensive case management and ACP undertaken with patients identified as 
being at increased risk of hospital admission in a Scottish general practice. An 
extended primary care team of case managers, a physiotherapist, an occupa-
tional therapist and care workers address unmet support needs, including 
through referral to other services. The programme includes rapid provision of 
home care and hospital-to-home transport.   
Yoo et al., 2012 
Integrated palliative care service, embedded within an intensive care unit 
(ICU) in a US hospital, with the aim of facilitating communications between 
health professionals and patients or families. 
Hamlet et al., 2010 
Telephone-based intervention in the US, where each patient has a designated 
nurse trained in end of life counselling. Sessions cover counselling about ADs, 
choice of aggressive vs palliative care and hospice enrollment. The nurse also 
facilitates interaction with physicans and hospice agencies or make other refer-
rals as required. 
Gade et al., 2008 
Integrated Palliative Care Service (IPCS) teams, in three US hospitals, includ-
ing a palliative care physician, palliative care nurse, hospital social worker and 
chaplain. The teams assess patients’ need for symptom management, psycho-
social and spiritual support, end-of-life planning and post-discharge care, and 
organise relevant follow-up and referrals. The discharge plan is communicated 
to primary care physicians via an electronic patient record. 
Engelhardt et al., 2006 
Advanced Illness Coordinated Care Program (AICCP), delivered in a series of 
healthcare settings over six sessions by a care coordinator. Sessions may cover 
a wide range of issues including ACP, completion of ADs, health literacy, pre-
paring questions for physician appointments, care coordination and referrals, 
addressing emotional and psychological needs, family communication etc. 
Molloy et al., 2000 
Let Me Decide AD programme in three nursing homes, involving education for 
hospital and nursing home staff about ADs and facilitation of ACP with pa-
tients and/or families of nursing home residents. 
Teno et al., 1997 
The SUPPORT study (Study to Understand Prognoses and Preferences for 
Outcomes and Risks of Treatments), conducted in five teaching hospitals in the 
US, including an intervention in which trained nurses had multiple contacts 
with patients, families, physicians and hospital staff to elicit preferences, im-
prove understanding of outcomes, facilitate ACP and physician-patient com-
munication. 
 
 
14 
Although ADs and other advance care plans are only operable when a patient loses 
capacity, none of the 18 studies limit their definition of ACP to these situations. Ex-
ceptionally, Weeks et al. (1994) report the number of patients who lost capacity and 
had their AD ‘activated’ but note that patients with ADs do not lose capacity fre-
quently enough for this to lead to significant healthcare savings. In practice, all of the 
studies assume that ACP can lead to healthcare savings for patients who do not lose 
capacity, but the mechanisms by which this is achieved are not well articulated. 
Weeks et al. (1994) suggest that engagement in ACP may enable patients to develop 
and better articulate their views on care priorities or the presence of an AD in medical 
notes may influence the care and treatment that physicians propose. However, none of 
the studies operationalise or test such hypotheses.  
 
Cost measurement 
 
No cost-effectiveness studies, involving the systematic identification of costs and out-
comes and the potential trade-offs between these, were identified. Rather, included 
studies can mostly be characterised as cost-savings studies, focused on identifying 
potential healthcare, and particularly hospital-based, cost savings. Healthcare costs, 
however, are defined and measured in a wide range of different ways (Table 3). Six of 
the studies use Medicare charges as their cost measure. Of these, Nicholas et al. 
(2014), Nicholas et al. (2011) and Kelley et al. (2011) use total Medicare charges, 
covering eligible care delivered in any setting. Hamlet et al. (2010) also use total 
Medicare charges, but exclude hospice care, while Kessler and McClellan (2004) use 
total Medicare charges but include co-payments and deductibles, additional costs that 
would normally be met by the patient, Medicaid or a Medigap supplementary or other 
insurance policy. Yoo et al. (2012) include charges to both Medicare and Medicaid 
but for hospital inpatient care only. Three of the studies use direct charges, made to 
the patient or their insurer (Weeks et al., 2004; Chambers et al., 2004; Teno et al., 
1997), with adjustments made for different patient factors. Seven studies use account-
ing costs, using a range of different accounting systems, assumptions and approaches, 
and either covering hospital services alone (Lukas at al., 2013; Abel et al., 2013; 
Baker et al., 2012; Tan and Jatoi, 2011) or a wider set of healthcare costs (Teo et al., 
2014; Gade et al., 2008; Engelhardt et al., 2006). Teo et al. (2014), additionally in-
clude nursing home costs, which they define as healthcare costs and are funded by the 
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Singapore Ministry of Health. Finally, two studies estimate costs using nationally cal-
culated average unit costs (Zhang et al., 2008; Molloy et al., 2000).  
 
Table 4: Operational definition of costs 
General (non-intervention) studies 
Nicholas et al., 2014 Medicare expenditure in last 6 months of life. 
Nicholas et al., 2011 Medicare expenditure in last 6 months of life. 
Kelley et al., 2011 Medicare expenditure in last 6 months of life.  
Tan et al., 2011 
Total hospital costs using accounting costs adjusted for age at death 
and length of stay.  
Zhang et al., 2008 
Hospital costs for one week before death, estimated using the National 
(Nationwide) Inpatient Sample, based on a national 20 per cent ran-
dom sample of hospital discharges. 
Kessler and McClel-
lan, 2004 
Total Medicare claims, including co-payments and deductibles, for last 
month of life. 
Weeks et al., 1994 
Physician and hospital charges for terminal admission adjusted by di-
agnosis related groups.  
Chambers et al., 1994 
Hospital charges adjusted by a range of factors, including clinical and 
demographic factors. 
 
Intervention studies 
Teo et al., 2014 
Per patient nursing home costs are derived by dividing total budget by 
number of patient days. Hospital, primary and other healthcare costs 
are based on average charge per day or unit cost, provided by the nurs-
ing home group finance department. Intervention costs are estimated 
using fixed costs along with estimated activity multiplied by hourly 
staff costs.  All estimates cover the last 3 months of life.  
Abel et al., 2013 
Actual costs of hospital treatment in last year of life adjusted for 
length of stay and complexity of care as per national agreement. 
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Lukas et al., 2013 
Total and variable hospital accounting costs, estimated for the period 
18 months pre-enrolment and compared to the period 18 months post-
enrolment.  
Baker et al., 2012 
Costs of unplanned hospitalisations are calculated using an NHS local 
patient-level information and costing system (PLICS), with data gath-
ered for three months prior to death for decedents and 12 months prior 
to, and following, the introduction of the intervention for survivors.  
Yoo et al., 2012 Total Medicare and Medicaid charges for index hospital admission. 
Hamlet et al., 2010 
Total Medicare expenditure in last 6 months of life, excluding hospice 
care. 
Gade et al., 2008 
Health service costs calculated using accounting costs, based on 
agreed rate structure/ contract rates, and covering costs for emergency 
department, clinic, hospital outpatient, home health visits, hospital re-
admissions, skilled nursing facility admissions and pharmacy. Inter-
vention costs estimated using staff time and wages. 
Engelhardt et al., 
2006 
Cost data for health services from participating Veteran Affairs medi-
cal centres cost records. Intervention costs calculated using contact 
time and salary for care coordinators and relevant overhead costs.  
Molloy et al., 2000 
Different healthcare interventions and services received by residents 
(covering hospital treatment, emergency department, physician consul-
tations, outpatient services, diagnostic procedures, surgical operations 
and pharmacy) were monitored and the costs of these estimated using 
unit costs derived from the Government-led Ontario Case Costing Pro-
ject and the Ontario fee schedule, Ontario Ministry of Health price list 
and the Ontario Drug Benefit formulary . 
Teno et al., 1997 
Hospital charges for index admission, adjusted by Therapeutic Intensi-
ty Scale Score (TISS) and length of stay. 
 
The use of these different cost measures produces different figures, since they effec-
tively measure different things. For example, charges made to Medicare are common-
ly lower than direct charges since Medicare does not cover all costs and is also able to 
negotiate volume discounts not available to individual health service users (Finkler, 
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1982). Charges may also be poorly aligned with underlying resource use (Finkler, 
1982). For example, in an analysis of data from one UK hospital trust, Blunt and 
Bardsley (2012) found that costs for delivering services were often very different 
from the tariff price paid by NHS commissioners, with only 17 per cent of patients 
incurring costs that fell within 10 per cent of the tariff price. The most appropriate 
measure, therefore, depends on what it is intended exactly to measure and the eco-
nomic perspective taken.   
 
Hamlet et al. (2010) evaluate an intervention explicitly designed to identify cost 
savings to Medicare. Commonly, however, the economic perspective taken is not 
explicit; although is implied in the cost measures chosen, which, in all of the studies, 
are limited to healthcare costs. Eight of the studies include community-based as well 
as hospital costs (Teo et al., 2014; Nicholas et al., 2014; Nicholas et al., 2011; Kelley 
et al., 2011; Hamlet et al., 2010; Gade et al., 2008, Engelhardt et al., 2006; Kessler 
and McClellan, 2004), although, the range of included services varies and it is often 
unclear whether all possible healthcare services are covered. Ten of the studies 
include only, or primarily, hospital costs (Abel et al., 2013; Lukas et al., 2013; Baker 
et al., 2012; Tan and Jatoi, 2011; Yoo et al., 2012; Zhang et al., 2009; Molloy et al., 
2000; Teno et al., 1997; Weeks et al., 1994; Chambers et al., 1994). Since reduced 
inpatient hospital care is likely to require substitution with community-based health 
and palliative care services (Yu et al., 2014; Kinley et al. 2014; Social Care Institute 
for Excellence, 2013; Emanuel and Emanuel, 1994), studies that focus only on 
hospital costs will fail to identify changes to these wider service costs.  
 
None of the studies takes a societal perspective, with all non-healthcare costs omitted 
from analyses. However, fewer hospitalisations and hospital deaths are likely to have 
impacts for unpaid family and other carers (Social Care Institute for Excellence, 2013; 
Newman, 2013; Kelley et al., 2011; McCrone, 2009; Dumont et al., 2009). These may 
include negative impacts, for example, on carers’ mental and physical health or their 
employment and finances (Funk et al., 2010) and on the total amount of unpaid care 
provided (Yu et al., 2014; McCrone, 2009). However, there may also be positive 
impacts, with ACP found in some studies to be associated with less depression and 
anxiety for carers (Detering et al., 2010; Wright et al., 2008). Reduced hospitalisation 
has also been associated with increased use of social care services in the UK 
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(Bardsley et al., 2012), although a follow-up study suggests these costs are unlikely to 
be high (Georghiou et al., 2014). Finally, the primary purpose of ACP is to improve 
people’s quality of life and reduce avoidable distress. In economic evaluations, it is 
increasingly common to use a health-related quality of life measure to generate 
estimates of quality-adjusted life years (QALY) (Petrou and Gray, 2011; NICE, 
2013), with the Palliative Care Yardstick (or PalY) promoted by some as a potential 
alternative measure (Normand, 2009; Round, 2012; Hughes, 2005; Gomes, 2009). 
However, none of the studies include such measures. The limited reach of cost 
measurement is explicitly acknowledged by some authors (Hamlet at al., 2010; Weeks 
et al., 1994).  
  
Intervention costs are also not always reported. Only four of the ten intervention stud-
ies report per-patient intervention costs (Teo et al., 2014; Gade et al., 2008, Engel-
hardt et al., 2006; Molloy et al, 2000), although Lukas et al. (2013) provide staffing 
and caseload information and Baker et al. (2012) provide an overall cost for the addi-
tional staffing required for the intervention. In the general ACP studies, we do not 
know whether or not patients received ACP facilitation and no costs for facilitation 
are included. The studies also vary in the period over which cost savings are meas-
ured, ranging from the last year (Abel et al., 2013) to the last week of life (Zhang et 
al., 2009), or not anchored by death at all, as in Baker et al. (2012), where costs are 
measured for a year post-intervention (Baker et al., 2012).  
 
 
Controlling for confounding variables 
 
Ethical and practical concerns mean that RCTs in end of life care research are diffi-
cult to implement (Higginson et al., 2013; Evans et al., 2014). Nonetheless, five stud-
ies (Hamlet et al., 2010; Gade et al., 2008; Englehardt et al., 2006; Molloy et al., 
2000; Teno et al., 1997) use randomised designs. The remaining studies take steps, 
using multivariate regression analyses, propensity score matching or other statistical 
approaches, to control for confounding variables. Kelley et al. (2011) in their analysis 
of data from the Health and Retirement Study include age, gender, ethnicity, sex, edu-
cation level, net worth, religiosity, self-rated health, having relatives nearby, marital 
status, residential status, type of non-Medicare insurance coverage (Medicaid, 
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Medigap or Veterans Administration), functional status, diagnosis and a range of re-
gional variables. Other studies using Health and Retirement Study data additionally 
include factors such as cognitive status, comorbidities and alternative regional varia-
bles such as nursing home capacity (Nicholas et al., 2014; Nicholas et al., 2011). Oth-
er observational studies control for a similar range of demographic and risk-related 
variables (Teo et al., 2012; Yoo et al., 2012; Tan and Jatoi, 2011; Zhang et al., 2009; 
Weeks et al., 1994; Chambers et al., 1994). In the UK, Baker et al. (2012) selected 
intervention and control groups using a predictive model for identifying those at risk 
of hospitalisation. However, the control group was located nearby so the authors were 
unable to control for factors affecting the area-wide health system. Also, because so 
few patients died over the course of the study, the sample of decedents (where posi-
tive results were identified) was effectively unmatched. Abel et al. (2013), in a study 
using a selective sample of primarily cancer patients under the care of a UK hospice, 
control for fewest factors, indicating that the age and gender profile of the ACP and 
non-ACP group were similar.  
 
Critically, in most of the observational studies, patient self-selection remains an im-
portant risk to validity, since it is possible, if not likely, that patients engaging in ACP 
may differ in their attitudes to dying or their perception of disease curability. They 
may also have doctors who favour less aggressive care or carers who are more sup-
portive of the withdrawal of curative care in the late stages of illness (Weekes et al., 
2010). Zhang et al. (2009), who found a positive association between ACP and hospi-
tal cost savings in the last week of life, is the only study to report primary data from 
patients and families. By using propensity score matching and data from interviews 
with patients and family, they are able to control for illness acknowledgement and 
treatment preferences. Unfortunately, the interview follows the occurrence of ACP (a 
prior discussion about end of life preferences with a physician), but is still conducted 
an average of 6 months before death.  
 
The economic effects of ACP 
 
Study findings are mixed, with little or no evidence that positive results are associated 
with whether the study is a general ACP or intervention study, the research design, 
sample size or setting. For example, of the eight studies that explore the impact of 
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ACP in general, just over half (five) report a statistically significant association be-
tween ACP and healthcare savings (Nicholas et al., 2014; Nicholas et al., 2011; Zhang 
et al., 2008; Weeks et al., 1994; Chambers et al., 1994). Of the ten intervention stud-
ies, exactly half (five) report a statistically significant association between the inter-
vention and healthcare savings (Teo et al., 2014; Lukas et al., 2013; Hamlet et al., 
2010; Gade et al., 2008; Molloy et al., 2000). With regard to research design, looking 
just at the five RCTs, just over half (three) report a statistically significant association 
between ACP and reduced healthcare costs (Hamlet et al., 2010; Gade et al., 2008; 
Molloy et al., 2000), while just over half (seven) of the 13 observational studies found 
a statistically significant association between ACP and reduced healthcare costs (Teo 
et al., 2014; Nicholas et al., 2014; Lukas et al., 2013; Nicholas et al., 2011; Zhang et 
al., 2009; Weeks et al., 1994; Chambers et al., 1994). There is also no apparent rela-
tionship between positive findings and sample size, although two studies that found 
no association had relatively small sample sizes and may have been under-powered 
(Tan and Jatoi, 2011; Engelhardt et al., 2006). Both nursing home-based studies found 
positive results (Teo et al., 2014; Molloy et al., 2000), however there was no clear 
pattern between positive results and other care-settings. 
 
Because of the different measures, cost savings figures are not comparable between 
studies. However, figures ranged (unadjusted for inflation) from $64,827 for the ter-
minal hospitalisation of decedents in a US hospital (Chambers et al., 1994), through 
$56,700 in total healthcare costs over six-months for high cost, low income Medicare 
beneficiaries (Hamlet et al., 2010) and $11,500 over last six-months of life for dece-
dents with dementia living in the community (Nicholas et al., 2014), to $1041 in hos-
pital costs over last week of life, for decedents with cancer (Zhang et al., 2009).  
 
All of the studies with positive results (with the exception of Teo et al., 2014 and 
Hamlet et al., 2010, which measured only costs) found corresponding reductions in a 
range of associated outcomes. These covered reductions in the following: hospital 
death and ICU use (Nicholas et al., 2014); hospitalisations, length of stay and 30-day 
re-admissions (Lukas et al., 2013); hospital deaths (Nicholas et al., 2011); ICU admis-
sions and aggressive treatments (Zhang et al., 2009); ICU use for patients re-admitted 
after the index hospitalisation (Gade et al., 2008); hospitalisations (Molley et al., 
2000); ICU use and major surgical treatments (Weeks et al., 1994) and ICU use, re-
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duced length of stay and billable procedures (Chambers et al., 1994). Although the 
association between ACP and cost savings was less clear in the two UK studies, 
Baker et al. (2012) found that ACP was associated with reduced hospitalisations and 
length of hospital stay for a small sample of decedents, albeit compared with an effec-
tively unmatched control group, and Abel et al. (2013) found that ACP was associated 
with reduced length of hospital stay in the last year of life, although not with a re-
duced number of hospital admissions.  
5. Conclusion 
 
Strengths and limitations 
 
Our review covers 24 years, capturing research dating back to the introduction of the 
US Patient Self-Determination Act (1990). It is wide ranging, covering all populations 
and settings, and provides an overview of the range and heterogeneity of economic 
studies in this area. However, the review is also subject to a number of limitations. 
The small number of relevant studies, the lack of cost-effectiveness studies, the meth-
odological limitations described and the fact that studies were highly heterogeneous, 
limit our ability to draw firm conclusions about the economic outcomes associated 
with ACP. It was also difficult to find an adequate search strategy given the diversity 
of the literature. Two studies were identified outside of the main search, one through a 
review of references and one independently known to the authors. It is also possible 
that we missed some relevant articles that did not refer to ACP in the abstract. How-
ever, the supplementary search of PubMed based on the MESH term ‘advance care 
planning’ identified no further relevant studies, providing some confidence that our 
initial search strategy was sufficiently rigorous. We included studies where ACP was 
a significant part of a wider intervention, thus overlapping with a broader literature on 
palliative care and end of life interventions. Some of these may include an element of 
ACP, but where ACP is not referred to in the title, abstract or key words we have as-
sumed it to be a less substantial aspect of an intervention.  
 
 
Summary and conclusion 
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Overall, evidence on the economic implications of ACP is limited and equivocal. 
However, the literature includes some well-conducted studies that find a statistically 
significant association between ACP (or interventions involving ACP facilitation as a 
significant element) and healthcare savings. In particular, there is evidence that ACP 
is associated with healthcare savings for some people in some circumstances, includ-
ing people living in nursing homes (Teo et al., 2014; Molloy et al., 2000), with high 
support needs and low income (Hamlet et al., 2010), living with dementia in the 
community (Nicholas et al., 2014) or living in a high-spending healthcare region 
(Nicholas et al., 2011).    
 
The vulnerability of observational studies to selection bias, particularly self-selection 
bias, is a significant challenge for research in this area. Brinkman-Stoppelenburg et al. 
(2014), in their systematic review of the (non-economic) effects of ACP on end of life 
care, consequently call for more experimental designs, with Halpern and Emanuel 
(2012) proposing cluster RCT designs, to address some of the ethical challenges asso-
ciated with experimental research. However, our review suggests that the challenges 
are not just those of managing selection biases, although this is important. The com-
plexity of ACP, the need to better understand the mechanisms linking ACP to 
healthcare savings and the potential for identifying and targetting populations and cir-
cumstances with the greatest potential for cost-effectiveness gains suggests a need for 
more mixed methods research (Higginson et al., 2013). This could include the use of 
realist approaches, which aim to make explicit and test causal pathways and are par-
ticularly suitable for evaluating complex interventions (Pawson and Tilley, 1997). 
There is also a need to ensure that the design and implementation of ACP interven-
tions in practice are effective (Lynn et al., 2000), suggesting a role for developmental 
research, implementation research and process evaluation.  
 
Finally, the identified studies focus exclusively on healthcare cost savings, potentially 
lending support to the view that interest in ACP is driven by a search for short-term 
cost savings (Halpern and Emanuel, 2012). Research into the economic implications 
of ACP would benefit from a longer-term perspective, with an emphasis not just on 
the impact on costs but also on cost-effectiveness, with more research undertaken to 
understand the impact on unpaid carers, greater consideration given to substitute 
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community-based care and efforts made to include quality of life benefits. While it 
can appear that policy makers and commissioners are interested in making cost sav-
ings, what they are generally trying to do is contain costs within the constraints of 
available budgets and allocate resources in ways that are efficient and equitable. It is 
important to develop further evidence on the economic implications of ACP to sup-
port policy-makers and commissioners in this task and to help ensure appropriate in-
vestment in end of life care services.   
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